Cargando…

Is targeting circulating T blood cells a therapeutic option for vitiligo?

Linked Article: Martins et al. Br J Dermatol 2020; 183:899–908.

Detalles Bibliográficos
Autor principal:	Matos, T.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687245/ https://www.ncbi.nlm.nih.gov/pubmed/32458433 http://dx.doi.org/10.1111/bjd.19126

Ejemplares similares

Follicular Unit Extraction as a Therapeutic Option for Vitiligo
por: Sacchidanand, S, et al.
Publicado: (2013)

Targeting gut microbiome, is it always a therapeutic option?
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2020)

Skin‐resident memory T cells as a potential new therapeutic target in vitiligo and melanoma
por: Willemsen, Marcella, et al.
Publicado: (2019)

The long road to valid outcomes in vitiligo
por: Wolkerstorfer, A.
Publicado: (2019)

Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009)

Advances in vitiligo: Update on therapeutic targets
por: Feng, Yifei, et al.
Publicado: (2022)

Pathophysiology and new targets for therapeutic options in Chagas heart disease
por: Ferreira, João Marcos B Barbosa
Publicado: (2022)

Utility of Blue Light in Dermoscopy for Diagnosing Stable Lesions in Vitiligo
por: Nirmal, Balakrishnan
Publicado: (2021)

The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets
por: Li, Lili
Publicado: (2020)

Promoting platelets is a therapeutic option to combat severe viral infection of the lung
por: Qiu, Jiahuang, et al.
Publicado: (2020)

Polyherbal formulation as a therapeutic option to improve wound healing in the diabetic foot
por: Papanas, N., et al.
Publicado: (2011)

Genetic understanding of vascular anomalies: better classification and risk‐stratification with targeted therapeutic options – a new horizon for vascular anomaly patients
por: van der Vleuten, C.J.M.
Publicado: (2022)

William Harvey and the discovery of the circulation of the blood
por: Ribatti, Domenico
Publicado: (2009)

Blood platelets: Circulating mirrors of neurons?
por: Canobbio, Ilaria
Publicado: (2019)

Anti‐CD20 therapeutic options in immune‐mediated thrombotic thrombocytopenic purpura
por: Maitta, Robert W.
Publicado: (2022)

Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers
por: Olivari, Alessandro, et al.
Publicado: (2023)

Commentary: Mechanical circulatory support for the failing Glenn circulation: Keep all options on the table and don't give up
por: Andersen, Nicholas D., et al.
Publicado: (2020)

Leukotrichia in Stable Segmental Vitiligo: Implication of an Alternate Treatment Option
por: Jee, Hyun Joong, et al.
Publicado: (2014)

There’s life in the old dog yet: vitamin C as a therapeutic option in endothelial dysfunction
por: Rodemeister, Sandra, et al.
Publicado: (2014)

A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
por: Criscuolo, Daniela, et al.
Publicado: (2022)

A Study of Hair Follicular Transplantation as a Treatment Option for Vitiligo
por: Thakur, Parul, et al.
Publicado: (2015)

Overview of Medical Therapies and Phototherapy in Vitiligo Based on Their Pathogenetic Action and the Role of Platelet-Rich Plasma
por: Sardana, Kabir, et al.
Publicado: (2018)

Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets
por: Dey-Rao, Rama, et al.
Publicado: (2017)

Early infant growth impairment in the setting of frequent exclusive breast feeding: considering therapeutic options
por: Nankabirwa, Victoria, et al.
Publicado: (2022)

Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo
por: Gianfaldoni, Serena, et al.
Publicado: (2018)

FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways
por: Rabik, Cara A., et al.
Publicado: (2020)

Third Combined South African Congress of the Dermatology, Dermatologic Surgery, and Vitiligo Societies, Pretoria, Republic of South Africa
por: Schwartz, Robert A, et al.
Publicado: (2020)

B cells as a therapeutic target in autoimmune disease
por: Goronzy, Jörg J, et al.
Publicado: (2003)

Vitiligo and the Role of Newer Therapeutic Modalities
por: Nimkar, Prathmesh, et al.
Publicado: (2022)

Hematopoietic stem cells: Can it be a therapeutic option for the hematopoietic failure in patients with trauma-hemorrhagic shock?
por: Kumar, Manoj, et al.
Publicado: (2016)

Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes: Is It a Solution?
por: Chatenoud, Lucienne
Publicado: (2013)

The Road to Toxin-Targeted Therapeutic Antibodies
por: Kozel, Thomas R.
Publicado: (2014)

Stem cell therapy: a novel treatment option for cerebral malaria?
por: Wang, Wei, et al.
Publicado: (2015)

Treatment options of lymphangioma circumscriptum
por: Puri, Neerja
Publicado: (2015)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

Protein translation controlled by the androgen receptor in prostate cancer: a novel therapeutic option?
por: Mirzakhani, Kimia, et al.
Publicado: (2020)

Options for Synthetic DNA Order Screening, Revisited
por: DiEuliis, Diane, et al.
Publicado: (2017)

Altered circulating memory T cells in vitiligo cases followed NB‐UVB therapy
por: Lin, Fuquan, et al.
Publicado: (2021)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

BAD: a good therapeutic target?
por: Motoyama, Andrea B, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_1bk9seqh845ld65q366kv03d2b